⌘K

Login Start Free

RESMED INC·4

Nov 16, 5:40 PM ET

Douglas Robert Andrew 4

4 · RESMED INC · Filed Nov 16, 2022

Insider Transaction Report

Form 4

Period: 2022-11-15

Douglas Robert Andrew

COO Asia Pacific

Transactions

Exercise/Conversion
ResMed Common Stock
2022-11-15$58.24/sh+16,888$983,557→ 51,466 total
Exercise/Conversion
ResMed Common Stock Options
2022-11-15−1,144→ 16,888 total
Exercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (1,144 underlying)
Exercise/Conversion
ResMed Common Stock
2022-11-15$58.24/sh+1,144$66,627→ 34,578 total
Sale
ResMed Common Stock
2022-11-15$222.07/sh−11,280$2,504,939→ 40,186 total
Exercise/Conversion
ResMed Common Stock Options
2022-11-15−16,888→ 0 total
Exercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (16,888 underlying)

Holdings

ResMed Common Stock
(indirect: By Trust)
227,708

Footnotes (3)

[F1]The transaction was conducted under a Rule 10b5-1 plan.
[F2]This transaction was executed in multiple trades at prices ranging from $221.77 $223.56. The price reported above reflects the weighted average sale price.
[F3]Represents date options first became exercisable. Options vest 1/3 per year.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT